Incremental prognostic value of immune cell densities beyond clinical parameters in non-small cell lung cancer
Clinical parameters remain the dominant predictors of outcome in NSCLC, with immune cell densities providing only limited prognostic value for clinical stratification. The openly available code and datasets present a unique resource for method development or focused analysis.
Authors
- Love Nordling
- Artur Mezheyeuski (ORCID: https://orcid.org/0000-0002-4394-2634)
- Patrick Micke (ORCID: https://orcid.org/0000-0003-1210-5961)
- Max Bäckman
- Natasa Sladoje
- Joakim Lindblad
Institutions
- Uppsala University (SE)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Vall d'Hebron Institute of Oncology (ES)
Publication Details
- Journal
- Lung Cancer
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.lungcan.2026.108935
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00